BACKGROUND/AIMS: In this study we tested the hypothesis that H(2)S regulates collagen deposition, matrix metalloproteinases (MMP) and inflammatory molecules during hyperhomocysteinemia (HHcy) resulting in attenuation of glomerulosclerosis and improved renal function. MATERIALS AND METHODS: A genetic model of HHcy, cystathionine beta-synthase heterozygous (CBS+/-) and wild-type (WT) 2-kidney (2K) mice were used in this study and supplemented with or without NaHS (30 micromol/l, H(2)S donor) in drinking water for 8 weeks. To expedite the renal damage associated with HHcy, uninephrectomized (1K) mice of similar groups were also used. RESULTS: Results demonstrated that NAD(P)H oxidase (p47(phox)subunit) and blood pressure were upregulated in WT 1K, CBS+/- 2K and CBS+/- 1K mice with downregulation of H(2)S production and reduced glomerular filtration rate. These changes were normalized with H(2)S supplementation. Both pro- and active MMP-2 and -9 and collagen protein expressions and glomerular depositions were also upregulated in WT 1K, CBS+/- 2K and CBS+/- 1K mice. Increased expressions of inflammatory molecules, intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1, as well as increased macrophage infiltration, were detected in WT 1K, CBS+/- 2K and CBS+/- 1K mice. These changes were ameliorated with H(2)S supplementation. CONCLUSION: Together, these results suggest that increased oxidative stress and decreased H(2)S in HHcy causes matrix remodeling and inflammation resulting in glomerulosclerosis and reduced renal function. 2010 S. Karger AG, Basel.
BACKGROUND/AIMS: In this study we tested the hypothesis that H(2)S regulates collagen deposition, matrix metalloproteinases (MMP) and inflammatory molecules during hyperhomocysteinemia (HHcy) resulting in attenuation of glomerulosclerosis and improved renal function. MATERIALS AND METHODS: A genetic model of HHcy, cystathionine beta-synthase heterozygous (CBS+/-) and wild-type (WT) 2-kidney (2K) mice were used in this study and supplemented with or without NaHS (30 micromol/l, H(2)Sdonor) in drinking water for 8 weeks. To expedite the renal damage associated with HHcy, uninephrectomized (1K) mice of similar groups were also used. RESULTS: Results demonstrated that NAD(P)H oxidase (p47(phox)subunit) and blood pressure were upregulated in WT 1K, CBS+/- 2K and CBS+/- 1K mice with downregulation of H(2)S production and reduced glomerular filtration rate. These changes were normalized with H(2)S supplementation. Both pro- and active MMP-2 and -9 and collagen protein expressions and glomerular depositions were also upregulated in WT 1K, CBS+/- 2K and CBS+/- 1K mice. Increased expressions of inflammatory molecules, intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1, as well as increased macrophage infiltration, were detected in WT 1K, CBS+/- 2K and CBS+/- 1K mice. These changes were ameliorated with H(2)S supplementation. CONCLUSION: Together, these results suggest that increased oxidative stress and decreased H(2)S in HHcy causes matrix remodeling and inflammation resulting in glomerulosclerosis and reduced renal function. 2010 S. Karger AG, Basel.
Authors: Jacek Rysz; Maciej Banach; Robert A Stolarek; Jaroslaw Pasnik; Aleksandra Cialkowska-Rysz; Robert Koktysz; Mariusz Piechota; Zbigniew Baj Journal: J Nephrol Date: 2007 Jul-Aug Impact factor: 3.902
Authors: Marie-Luise Brezniceanu; Fang Liu; Chih-Chang Wei; Isabelle Chénier; Nicolas Godin; Shao-Ling Zhang; Janos G Filep; Julie R Ingelfinger; John S D Chan Journal: Diabetes Date: 2007-10-31 Impact factor: 9.461
Authors: Kotaro Kida; Shizuka Minamishima; Huifang Wang; JiaQian Ren; Kazim Yigitkanli; Ala Nozari; Joseph B Mandeville; Philip K Liu; Christina H Liu; Fumito Ichinose Journal: Resuscitation Date: 2012-02-25 Impact factor: 5.262
Authors: Eelke M Bos; Rui Wang; Pauline M Snijder; Miriam Boersema; Jeffrey Damman; Ming Fu; Jill Moser; Jan-Luuk Hillebrands; Rutger J Ploeg; Guangdong Yang; Henri G D Leuvenink; Harry van Goor Journal: J Am Soc Nephrol Date: 2013-02-28 Impact factor: 10.121
Authors: P M Snijder; A R Frenay; R A de Boer; A Pasch; J L Hillebrands; H G D Leuvenink; H van Goor Journal: Br J Pharmacol Date: 2015-03 Impact factor: 8.739